Canopy Growth Corporation: Business Overview, Financials & Competitive Analysis
Canopy Growth Corporation scores 6/10 on the AskCyborg Cyborg Score (Solid). Canopy is executing operational improvements and strategic expansion through the MTL acquisition, but faces margin pressures and regulatory headwinds. The company improved earnings per share loss and demonstrates encouraging operational cash flow showing strong financial health. However, analysts have lowered price targets citing uncertainties about gross margins and regulatory.
What is Canopy Growth Corporation's industry? Canopy Growth Corporation (canopygrowth.com) operates in Cannabis & Hemp Products - Medical & Adult-Use. AskCyborg classifies Canopy Growth Corporation under Cannabis & Hemp Products - Medical & Adult-Use in its company registry.
Canopy Growth is a world-leading cannabis company delivering innovative products from owned and licensed brands including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as vaporization devices by Storz & Bic...
Cyborg Score thesis
Canopy is executing operational improvements and strategic expansion through the MTL acquisition, but faces margin pressures and...
Read the full analyst-debate transcript →Get the Latest Canopy Growth Corporation Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeCanopy Growth Corporation Overview
Pro stress-test →Canopy Growth is a world-leading cannabis company delivering innovative products from owned and licensed brands including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as vaporization devices by Storz & Bickel, serving medical cannabis patients globally with principal operations in Canada, Europe and Australia. In Q3 FY2026, the company achieved double-digit net revenue growth, reporting C$90.39M, up from C$86.24M.
Strategic Profile
Pro stress-test →The company is completing a strategically compelling combination with MTL Cannabis to create Canada's leading medical cannabis company. Canopy has established a comprehensive ecosystem for the U.S. THC market through a non-controlling interest in Canopy USA, which includes ownership of Acreage Holdings, Wana Wellness, and other cannabis-related entities. Storz & Bickel devices benefited from strong seasonal demand with VEAZY becoming the company's best-selling device with the fastest ramp to 20,000 units sold.
Competitive Landscape
Pro stress-test →Canopy operates through four segments: Canada Cannabis, International Markets Cannabis, Storz & Bickel, and This Works. Main competitors include other licensed cannabis producers in Canada and international markets, vaporization device manufacturers, and U.S. multi-state operators. Canopy USA portfolio includes Acreage Holdings with operations throughout the U.S. Northeast and Midwest.
Industry Context
Canopy Growth Corporation operates in Cannabis & Hemp Products - Medical & Adult-Use.
Key facts
Founded: 2015 · Headquarters: Smiths Falls, Canada · Revenue: C$268.99M